Interventions Testing Program (ITP): Difference between revisions

Line 20: Line 20:


* '''Acarbose:''' Identified in multiple studies (Harrison 2014, Strong 2016, Harrison 2019), acarbose has been shown to extend lifespan. It is primarily used in the medical field to treat type 2 diabetes by inhibiting enzymes that digest carbohydrates, thereby reducing glucose absorption.
* '''Acarbose:''' Identified in multiple studies (Harrison 2014, Strong 2016, Harrison 2019), acarbose has been shown to extend lifespan. It is primarily used in the medical field to treat type 2 diabetes by inhibiting enzymes that digest carbohydrates, thereby reducing glucose absorption.
* '''Aspirin:''' Aspirin was found to have lifespan-extending properties as reported in Strong 2008. Commonly known for its use as a pain reliever and anti-inflammatory, its role in longevity research adds a new dimension to its therapeutic potential.
* '''Aspirin:''' Aspirin was found to have lifespan-extending properties as reported in Strong 2008. Commonly known for its use as a pain reliever and anti-inflammatory, its role in longevity research adds a new dimension to its therapeutic potential.
* '''Canagliflozin:''' Identified in Miller 2020, canagliflozin is primarily used to treat type 2 diabetes. It works by inhibiting the sodium-glucose transport protein, which helps to reduce blood sugar levels.
* '''Canagliflozin:''' Identified in Miller 2020, canagliflozin is primarily used to treat type 2 diabetes. It works by inhibiting the sodium-glucose transport protein, which helps to reduce blood sugar levels.
* '''Captopril:''' Discovered to increase lifespan in Strong 2022, captopril is typically employed as a treatment for hypertension and certain types of heart failure.
* '''Captopril:''' Discovered to increase lifespan in Strong 2022, captopril is typically employed as a treatment for hypertension and certain types of heart failure.